MicroRNA-20a suppresses tumor proliferation and metastasis in hepatocellular carcinoma by directly targeting EZH1.

Hepatocellular carcinoma (HCC), a worldwide leading cause of morbidity and mortality, is the most frequent primary liver tumor. Most HCC patients are diagnosed with advanced liver cancer, resulting in a very low 5-year survival rate.